Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash & Current Investments: 2013-2025

Historic Cash & Current Investments for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $85.3 million.

  • Phibro Animal Health's Cash & Current Investments fell 5.08% to $85.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $299.7 million, marking a year-over-year decrease of 24.25%. This contributed to the annual value of $77.0 million for FY2025, which is 32.78% down from last year.
  • According to the latest figures from Q3 2025, Phibro Animal Health's Cash & Current Investments is $85.3 million, which was up 10.69% from $77.0 million recorded in Q2 2025.
  • Phibro Animal Health's 5-year Cash & Current Investments high stood at $114.6 million for Q2 2024, and its period low was $67.1 million during Q4 2024.
  • Moreover, its 3-year median value for Cash & Current Investments was $85.3 million (2025), whereas its average is $85.9 million.
  • As far as peak fluctuations go, Phibro Animal Health's Cash & Current Investments spiked by 41.01% in 2024, and later tumbled by 32.78% in 2025.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Cash & Current Investments stood at $95.5 million in 2021, then dropped by 17.87% to $78.4 million in 2022, then increased by 17.94% to $92.5 million in 2023, then fell by 27.48% to $67.1 million in 2024, then dropped by 5.08% to $85.3 million in 2025.
  • Its Cash & Current Investments was $85.3 million in Q3 2025, compared to $77.0 million in Q2 2025 and $70.4 million in Q1 2025.